Enochian BioSciences, Inc.: Enochian BioSciences' CEO Letter to Shareholders
Turning the Page; A Promising FutureLOS ANGELES, April 03, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: ENOB) -- Accelerated Pre-Investigational New Drug (Pre-IND) submission to the US Food and Drug Administration
Source: finanznachrichten.de